Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase that was initially discovered and characterized in a rare type of lymphoma called anaplastic large-cell lymphoma (ALCL) as an NPM-ALK fusion protein [2]. This evidence concerns the gene ALK and anaplastic large cell lymphoma.